ACE2 and COVID-19: Overall, the clinical findings at present contest the hypothesis of increased Ang II and decreased ACE2 in COVID-19 as a systemic phenomenon, while these changes might well play a role locally within the lung tissue (Gerard et al., 2021; Iwasaki et al., 2021).